Phase-II Multicentric Clinical Study to Assess the Performance of the Xpert MTB/XDR Assay for INH and Second-Line Resistance Detection ? Xpert MTB/XDR Clinical Evaluation
Implementing Organization
National Institute of Tuberculosis and Respiratory Diseases (NITRD)
Principal Investigator
Dr Vithal Prasad Myneedu
National Institute of Tuberculosis and Respiratory Diseases (NITRD)
Foundation for Innovative New Diagnostics (FIND), Switzerland
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Tuberculosis
Start Year
2019
End Year
2020
Sanction Amount
₹ 36.53 L
Status
Completed
Contact
v.myneedu@nitrd.nic.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
NA
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
National Institute of Tuberculosis and Respiratory Diseases (NITRD)
Acces sibility Controls